These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17562541

  • 1. Androgens and prostate cancer risk: a prospective study.
    Wirén S, Stocks T, Rinaldi S, Hallmans G, Bergh A, Stenman UH, Kaaks R, Stattin P.
    Prostate; 2007 Aug 01; 67(11):1230-7. PubMed ID: 17562541
    [Abstract] [Full Text] [Related]

  • 2. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.
    Cancer Epidemiol Biomarkers Prev; 2005 May 01; 14(5):1262-9. PubMed ID: 15894683
    [Abstract] [Full Text] [Related]

  • 3. Circulating steroid hormones and the risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan 01; 15(1):86-91. PubMed ID: 16434592
    [Abstract] [Full Text] [Related]

  • 4. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
    Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov 01; 6(11):967-9. PubMed ID: 9367072
    [Abstract] [Full Text] [Related]

  • 5. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 6. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ.
    J Natl Cancer Inst; 1996 Aug 21; 88(16):1118-26. PubMed ID: 8757191
    [Abstract] [Full Text] [Related]

  • 7. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 21; 12(12):1410-6. PubMed ID: 14693730
    [Abstract] [Full Text] [Related]

  • 8. Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III).
    Rohrmann S, Nelson WG, Rifai N, Kanarek N, Basaria S, Tsilidis KK, Smit E, Giovannucci E, Platz EA.
    Urology; 2007 Apr 21; 69(4):708-13. PubMed ID: 17445656
    [Abstract] [Full Text] [Related]

  • 9. Serum androgens: associations with prostate cancer risk and hair patterning.
    Demark-Wahnefried W, Lesko SM, Conaway MR, Robertson CN, Clark RV, Lobaugh B, Mathias BJ, Strigo TS, Paulson DF.
    J Androl; 1997 Apr 21; 18(5):495-500. PubMed ID: 9349747
    [Abstract] [Full Text] [Related]

  • 10. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM.
    Cancer Epidemiol Biomarkers Prev; 2006 Jul 21; 15(7):1331-5. PubMed ID: 16835332
    [Abstract] [Full Text] [Related]

  • 11. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
    Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P, Metter EJ.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep 21; 14(9):2257-60. PubMed ID: 16172240
    [Abstract] [Full Text] [Related]

  • 12. Radical prostatectomy: influence on serum and urinary androgen levels.
    Olsson M, Ekström L, Schulze J, Kjellman A, Akre O, Rane A, Gustafsson O.
    Prostate; 2010 Feb 01; 70(2):200-5. PubMed ID: 19760638
    [Abstract] [Full Text] [Related]

  • 13. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
    Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R.
    J Clin Oncol; 2004 Aug 01; 22(15):3104-12. PubMed ID: 15284261
    [Abstract] [Full Text] [Related]

  • 14. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies.
    Eaton NE, Reeves GK, Appleby PN, Key TJ.
    Br J Cancer; 1999 Jun 01; 80(7):930-4. PubMed ID: 10362098
    [Abstract] [Full Text] [Related]

  • 15. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study.
    Heikkilä R, Aho K, Heliövaara M, Hakama M, Marniemi J, Reunanen A, Knekt P.
    Cancer; 1999 Jul 15; 86(2):312-5. PubMed ID: 10421267
    [Abstract] [Full Text] [Related]

  • 16. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E.
    Endocr Relat Cancer; 2005 Dec 15; 12(4):1071-82. PubMed ID: 16322344
    [Abstract] [Full Text] [Related]

  • 17. Reduced circulating androgen bioactivity in patients with prostate cancer.
    Raivio T, Santti H, Schatzl G, Gsur A, Haidinger G, Palvimo JJ, Jänne OA, Madersbacher S.
    Prostate; 2003 May 15; 55(3):194-8. PubMed ID: 12692785
    [Abstract] [Full Text] [Related]

  • 18. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
    Dalais FS, Meliala A, Wattanapenpaiboon N, Frydenberg M, Suter DA, Thomson WK, Wahlqvist ML.
    Urology; 2004 Sep 15; 64(3):510-5. PubMed ID: 15351581
    [Abstract] [Full Text] [Related]

  • 19. Hormonal predictors of prostate cancer.
    Sofikerim M, Eskicorapci S, Oruç O, Ozen H.
    Urol Int; 2007 Sep 15; 79(1):13-8. PubMed ID: 17627161
    [Abstract] [Full Text] [Related]

  • 20. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M.
    Int J Cancer; 2004 Jan 20; 108(3):418-24. PubMed ID: 14648709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.